Abstract:Tuberculosis (TB) remains a global public health threat. Understanding the dynamics of host-pathogen interactions within TB granulomas will assist in identifying what leads to the successful elimination of infection. In vitro TB models provide a controllable environment to study these granuloma dynamics. Previously we developed a biomimetic 3D spheroid granuloma model that controls bacteria better than a traditional monolayer culture counterpart. We used agent-based simulations to predict the mechanistic reason for this difference. Our calibrated simulations were able to predict heterogeneous bacterial dynamics that are consistent with experimental data. In one group of simulations, spheroids are found to have higher macrophage activation than their traditional counterparts, leading to better bacterial control. This higher macrophage activation in the spheroids was not due to higher counts of activated T cells, instead fewer activated T cells were able to activate more macrophages due to the proximity of these cells to each other within the spheroid. In a second group of simulations, spheroids again have more macrophage activation but also more T cell activation, specifically CD8+ T cells. This higher level of CD8+ T cell activation is predicted to be due to the proximity of these cells to the cells that activate them. Multiple mechanisms of control were predicted. Simulations removing individual mechanisms show that one group of simulations has a CD4+ T cell dominant response, while the other has a mixed/CD8+ T cell dominant response. Lastly, we demonstrated that in spheroids the initial structure and movement rules work synergistically to reduce bacterial load. These findings provide valuable insights into how the structural complexity of in vitro models impacts immune responses. Moreover, our study has implications for engineering more physiologically relevant in vitro models and advancing our understanding of TB pathogenesis and potential therapeutic interventions. Tuberculosis (TB) is a respiratory infection that is associated with granulomas, organized clusters of immune cells that form around the bacteria. Recent work has focused on making in vitro models that better approximate these granulomas, such as our spheroid granuloma model. We found that this spheroid was better able to control bacteria than its traditional culture counterpart, so, in this work, we use agent-based modeling to explore the causes of this differential control. The simulated spheroids have increased macrophage activation. Surprisingly, this is not due to larger numbers of activated T cells, which activate these macrophages. Rather, the increase in activated macrophages is due to their proximity to fewer activated T cells. We also see a subset of simulations where the spheroids have increased cytotoxic CD8+ T cell activation. The simulation is further used to simulate changes in the structure of the in vitro models to explore its impact on immune response and bacterial control. These findings reveal the importance of structural complexity in in vitro models and offer insights into TB pathogenesis. Ultimately, our work paves the way for more realistic in vitro models and a deeper understanding of how our bodies combat TB.

In silico agent-based modeling approach to characterize multiple in vitro tuberculosis infection models

Agent-based model predicts that layered structure and 3D movement work synergistically to reduce bacterial load in 3D in vitro models of tuberculosis granuloma

Agent-based modelling of Mycobacterium tuberculosis transmission: a systematic review

One Size Fits All? Not in in Vivo Modeling of Tuberculosis Chemotherapeutics

Physiological modeling of the metaverse of the Mycobacterium tuberculosis β-CA inhibition mechanism

Verification of an agent-based disease model of human mycobacterium tuberculosis infection

Development and Analysis of Multiscale Models for Tuberculosis: From Molecules to Populations

Integrating Agent-Based and Compartmental Models for Infectious Disease Modeling: A Novel Hybrid Approach

THP-1 Cell Line Model for Tuberculosis: A Platform for in Vitro Macrophage Manipulation.

The – infection model, a powerful high throughput screening platform for anti-infective compounds

Advances in an In Vitro Tuberculosis Infection Model Using Human Lung Organoids for Host-Directed Therapies

Dynamics of a Tuberculosis Outbreak Model in a Multi-scale Environment

Computational pharmacokinetics/pharmacodynamics of rifampin in a mouse tuberculosis infection model

In-silico studies of anti-tuberculosis drugs using advanced computational techniques

Applying geospatial multi-agent system to model various aspects of tuberculosis transmission

Deterministic and stochastic in-host tuberculosis models for bacterium-directed and host-directed therapy combination

A data and knowledge-driven integrated modeling approach to organ-specific Tuberculosis subtype discovery: A one health paradigm

Timing matters in Macrophage / CD4+ T cell interactions: An agent-based model comparing host-pathogen interactions between latently infected and naïve individuals

A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations

Three‐Dimensional Culture Modelling Reveals Divergent Mycobacterium tuberculosis Virulence and Antimicrobial Treatment Response

A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum